vTv Therapeutics Inc.
VTVT
$25.24
$1.747.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 71.09% | 44.98% | |||
| Gross Profit | -71.09% | -44.98% | |||
| SG&A Expenses | 1.69% | -1.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 38.57% | 18.73% | |||
| Operating Income | -38.57% | -18.73% | |||
| Income Before Tax | -40.18% | -18.71% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -40.18% | -18.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 23.46% | 18.58% | |||
| Net Income | -43.86% | -18.74% | |||
| EBIT | -38.57% | -18.73% | |||
| EBITDA | -38.60% | -18.85% | |||
| EPS Basic | 23.63% | -18.67% | |||
| Normalized Basic EPS | 21.98% | -18.67% | |||
| EPS Diluted | 23.63% | -18.67% | |||
| Normalized Diluted EPS | 21.98% | -18.67% | |||
| Average Basic Shares Outstanding | 88.38% | 0.07% | |||
| Average Diluted Shares Outstanding | 88.38% | 0.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||